Skip to content
Wednesday, February 11, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • It’s not just the kids: A third of US Jews 75+ don’t call themselves ‘Zionists’ February 11, 2026
  • A Satisfied Mind February 11, 2026
  • Florida’s anti-Israel GOP candidate James Fishback is railing against ‘goyslop.’ What is he talking about? February 10, 2026
  • Oklahoma board denies proposal for Jewish charter school — and lawyers up ahead of expected legal battle February 10, 2026
  • 1 in 3 American Jews were targeted by an antisemitic incident last year, AJC survey finds February 9, 2026
  • Did Bad Bunny’s Music Overcome His Politics? February 9, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.